     |
|||||||||||||||||||
|
|
|||||||||||||||||||
Cancer TestsThere are numerous cancer detection and prevention tests that can be used to detect cancer. Some tests that are considered alternative, or less toxic than other standard conventional tests. Some of these tests are not used by conventional physicians, but you can always ask them to look into the test. It is important to understand that one should not rely on any one test - some tests can result in false positives or negatives. One must take all clinical factors into consideration to back up a diagnosis. Some of the tests you may have when doctors are diagnosing or treating your cancer. You may also be asked to have tests as part of your routine follow up once your treatment is over. Specific cancer tests are CT scan, MRI scan, Ultrasound scan, Bone scan, PET Scan, Bone marrow test, Barium X-ray, Endoscopy, Lymphangiogram, IVU (Intravenous urogram) or IVP (IV pyelogram), Lumbar puncture, Cystoscopy.
 2010-03-13 PSA Test Reduces Prostate Cancer Deaths by 40 pct. -- WASHINGTON /PRNewswire-USNewswire/ --Contrary to ACS claims, medical data suggest mammograms and PSA testing are effective. Based on data by the U. S. Preventive Services Task Force (USPSTF), mammography screening has led to a 15 percent reduction in breast cancer deaths. USPSTF also references an ongoing screening study where early detection (using the PSA test) has so far reduced prostate cancer deaths by 20 percent. These include the American Urological Association, National Comprehensive Cancer Network, Prostate Cancer Foundation, Prostate Cancer Research Institute, Malecare Prostate Cancer Support, Mens Health Network, National Alliance of State Prostate Cancer Coalitions, Prostate Cancer International, Prostate Conditions Education Council, Prostate Health Education Network, The Prostate Net, Us TOO International Prostate Cancer Education and Support Network, and Women Against Prostate Cancer. PSA Test Reduces Prostate Cancer Deaths by 40 pct. - ZERO - The Project to End Prostate Cancer District of Columbia POL HEA MTC
2010-03-12 Vermillion, Quest Diagnostics Launch OVA1 Ovarian Cancer Test ProteoMonitor Proteomics GenomeWebClinical practice guidelines recommend patients with ovarian cancer to be under the care of a gynecological surgeon, but current pre-clinical tests for ovarian masses, such as CT scans and ultrasound, can be inconclusive about the evidence of cancer, Quest and Vermillion said. About one-third of initial surgeries for ovarian cancer are performed by gynecological surgeons. In a prospective clinical study, OVA1, combined with pre-surgical clinical and radiological assessments used by non-gynecologic oncologists, detected 92 percent of malignant ovarian masses compared to 72 percent without OVA1. Also, 14 of the 20 women in the trial whose cancer was missed by pre-surgical clinical and radiological assessments would have been identified as having malignant masses if OVA1 results had been evaluated before their surgeries, Vermillion and Quest said.
2010-03-10 Ontario begins funding breast-cancer test - The Globe and MailOntario begins funding breast-cancer test The new practice, which began last month, came after The Globe and Mail reported in December that 130 Canadian women had paid out of pocket to undergo the Oncotype DX test in the United States because it was not covered here. The test analyzes 21 genes that can help predict whether a cancer is likely to return within the next decade. Coree Hanczyk, 45, had a molecular test for breast cancer and was able to skip chemotherapy altogether. Though the test cost her usd. 4,100 out of pocket, she saved the health-care system many thousands more in chemotherapy costs. Genetic risk assessment could eliminate unnecessary chemotherapy and save money for the health-care system - Cancer ontario testing breast cancer canada chemotherapy
2010-03-04 Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer RecurrencePROLARIS is a molecular diagnostic assay that offers urologists a more accurate way of determining a prostate cancer patients risk of recurrence. The new molecular diagnostic test is based on cell growth and tumor biology and provides rigorous, quantitative measures of the expression levels of multiple genes related to progression of the cell cycle. The Company is performing additional clinical validation studies to expand the utility of PROLARIS. In one such recently completed study of 365 prostate cancer patients, 98. 5 pct. of prostate cancer patients with a low (favorable) PROLARIS score survived their disease after 10 years, compared to 57. 6 pct. of the patients receiving a high (unfavorable) score who died of prostate cancer within 10 years.
2010-03-02 BBC News - Gene test aid to cancer treatmentGene test aid to cancer treatment Study leader, Dr Charles Swanton, head of translational cancer therapeutics at the Institute, said one of the great challenges in cancer medicine is determining which patients will benefit from particular cancer drugs, which are in themselves toxic and carry severe side effects. Dr Lesley Walker, Cancer Research UKs director of cancer information, said: "New techniques such as these can enable drugs to be tailored to individual patients, and this could potentially improve cancer survival in the long term. Scientists develop a gene test which predicts how well chemotherapy will work in individual breast cancer patients. - BBC News BBC News news online world uk international foreign british online service
2010-03-01 Fears grip Windsor in wake of medical mistakesMore than a month after his visit to Ling, DeRoy says Ling called his wife to say everything was fine and he didnt have cancer. DeRoy says he immediately called Lings office back to see if he should still go for cancer treatment that had been scheduled for the next week and was told by the receptionist Ling wanted him to go. However, later that fall, DeRoy, 33, says he was told he didnt have cancer after his pathology test came back from Mount Sinai Hospital in Toronto. WINDSOR, ONT. Imagine believing youre living with a death sentence when youre young, married and have big plans for your three children. Thats what. - HealthZone News and Features
2010-02-26 Vital Signs - Prevention - Older Women Are Not Likely to Benefit From Cervical Cancer VaccinePublished online in The Journal of the National Cancer Institute. The study followed more than 9,000 Costa Rican women ages 19 to 97, screening them for carcinogenic HPV infections and precursors to cervical cancer. The rate of newly detected infections dropped with age to 13. 5 percent in women 42 and older, from 35 percent in women 18 to 25. In younger and older women alike, new infections generally cleared up without treatment, usually within two years. The vaccine for HPV, the virus that causes cervical cancer, is used to prevent new infections, but those occur less frequently in women over 40, a study found. - Human Papilloma Virus (HPV) Cervix Women and Girls Medicine and Health Vaccination and Immunization
2010-02-25 New test a glimmer of hope in the fight against ovarian cancerAlthough a report out today from the Australian Institute of Health and Welfare shows improvements in the survival rate, it is still less than half that for breast cancer, and developing a screening test to detect the cancer in its early stages remains a challenge. The new Lowy Cancer Research Centre at the University of NSW and the GO Research Fund, part of the Royal Hospital for Women, will work on a usd. 1 million project over the next three years with the aim of developing a blood test to screen healthy women.
2010-02-24 Do Hot Dogs, Grapes Need Warning Labels for Children - WBAY-TV Green Bay-Fox Cities-Northeast Wisconsin News:Scientists have created a new test that could help cancer patients make their treatment more personalized. Its a blood test that looks at the genetic makeup of a patients cancer cells. The test shows how well the treatment is knocking out cancer cells from the body. Experts say every patients cancer is different, and treatment could be more effective if doctors can customize it. And Action 2 News deliver breaking news, top story headlines, weather, radar, sports and community information for Northeast Wisconsin - WBAY TV channel 2, Green Bay, Wisconsin - Wbay tv 2 abc channel 2 Green Bay Wisconsin news Appleton Oshkosh wbay weather weather doppler radar sports Green Bay Packers sudoku community calendar
|
|
||||||||||||||||||
|
|||||||||||||||||||
